Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Spiera

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisRuth J Pepper, Juliana B Draibe, Ben Caplin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2018
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient SubsetsEli M Miloslavsky, Na Lu, Sebastian Unizony, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisRuth J Pepper, Juliana B Draibe, Ben Caplin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2018
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.
Pageof 10